Bacoside-A inhibits membrane interactions of prion protein amyloid fragment.
Bacoside-A/PrP(106–126) interactions in vesicle solutions enhance fibril formation.
Lower amyloid toxicity linked to inhibited fibrillation and membrane binding.
Results might shed light on putative therapeutic effects of bacoside-A.